IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Infectious Disorders - Drug Targets

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

1.26

h-Index

2024-2025

 63

Rank

2024-2025

 17019

SJR

2024-2025

 0.288

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Infectious Disorders - Drug Targets
Abbreviation Infect. Disord. - Drug Targets
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)
h-index 63
Overall Rank/Ranking 17019
SCImago Journal Rank (SJR) 0.288
Impact Score 1.26
Publisher Bentham Science Publishers
Country United Arab Emirates
ISSN 22123989, 18715265
Best Quartile Q3
Coverage History 2006-2025




About Infectious Disorders - Drug Targets


Infectious Disorders - Drug Targets is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3); Molecular Medicine (Q4). It is published by Bentham Science Publishers. The overall rank of Infectious Disorders - Drug Targets is 17019. According to SCImago Journal Rank (SJR), this journal is ranked 0.288. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 63. The best quartile for this journal is Q3.

The ISSN of Infectious Disorders - Drug Targets journal is 22123989, 18715265. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Infectious Disorders - Drug Targets is cited by a total of 392 articles during the last 3 years (Preceding 2024).


Infectious Disorders - Drug Targets Impact IF 2024-2025


The Impact IF 2024 of Infectious Disorders - Drug Targets is 1.26, which is computed in 2025 as per its definition. Infectious Disorders - Drug Targets IF is decreased by a factor of 0.21 and approximate percentage change is -14.29% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Infectious Disorders - Drug Targets Impact IF 2025 Prediction


Impact IF 2024 of Infectious Disorders - Drug Targets is 1.26. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of Infectious Disorders - Drug Targets. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 1.26
2023 1.47
2022 1.40
2021 1.28
2020 1.42
2019 1.05
2018 0.87
2017 0.95
2016 1.39
2015 1.20
2014 1.72

Infectious Disorders - Drug Targets h-index


  Table Setting

Infectious Disorders - Drug Targets has an h-index of 63. It means 63 articles of this journal have more than 63 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Infectious Disorders - Drug Targets ISSN


The ISSN of Infectious Disorders - Drug Targets is 22123989, 18715265. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Infectious Disorders - Drug Targets Rank and SCImago Journal Rank (SJR)


The overall rank of Infectious Disorders - Drug Targets is 17019. According to SCImago Journal Rank (SJR), this journal is ranked 0.288. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Infectious Disorders - Drug Targets by Year


Year SJR
2025/2026 Coming Soon
2024 0.288
2023 0.338
2022 0.298
2021 0.319
2020 0.322
2019 0.267
2018 0.351
2017 0.323
2016 0.554
2015 0.778
2014 0.808

Ranking of Infectious Disorders - Drug Targets by Year


Year Ranking
2025/2026 Coming Soon
2024 17019
2023 14621
2022 15193
2021 14228
2020 14121
2019 15533
2018 12403
2017 12683
2016 8498
2015 6106
2014 5674

Infectious Disorders - Drug Targets Publisher


Table Setting

Infectious Disorders - Drug Targets is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Infectious Disorders - Drug Targets is Infect. Disord. - Drug Targets. This abbreviation ('Infect. Disord. - Drug Targets') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Infectious Disorders - Drug Targets


If your research field is/are related to Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3); Molecular Medicine (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Infectious Disorders - Drug Targets?

Infectious Disorders - Drug Targets latest impact IF is 1.26. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 1.72 (2014) and 0.87 (2018), respectively, in the last 11 years. Moreover, its average IS is 1.27 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Infectious Disorders - Drug Targets?

The Infectious Disorders - Drug Targets has an SJR (SCImago Journal Rank) of 0.288, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.808 in 2014 and the lowest being 0.267 in 2019. Furthermore, the average SJR of the Infectious Disorders - Drug Targets over the previous 11-year period stands at 1.27.


What's the latest h-index of the Infectious Disorders - Drug Targets?

The latest h-index of the Infectious Disorders - Drug Targets is 63.


Who's the publisher of the Infectious Disorders - Drug Targets?

The Infectious Disorders - Drug Targets is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.


What's the current ranking of the Infectious Disorders - Drug Targets?

The Infectious Disorders - Drug Targets is currently ranked 17019 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 5674 in 2014 and its lowest position of 17019 in 2024.


What's the abbreviation or short name for the Infectious Disorders - Drug Targets?

The standard ISO4 abbreviation for the Infectious Disorders - Drug Targets is Infect. Disord. - Drug Targets.


Is the "Infectious Disorders - Drug Targets" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Infectious Disorders - Drug Targets is classified as a journal that the Bentham Science Publishers publishes.


What's the scope or major areas of the Infectious Disorders - Drug Targets?

The Infectious Disorders - Drug Targets encompasses the following areas:

  • Medicine (miscellaneous)
  • Microbiology (medical)
  • Pharmacology
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Infectious Disorders - Drug Targets?

The Infectious Disorders - Drug Targets is assigned the following International Standard Serial Numbers (ISSN): 22123989, 18715265.


What's the best quartile of the Infectious Disorders - Drug Targets?

The best quartile for the Infectious Disorders - Drug Targets is Q3 (2024).


What's the coverage history of the Infectious Disorders - Drug Targets?

The Infectious Disorders - Drug Targets coverage history can be summarized as follows: 2006-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Clinical Medicine and Research journal 14921 Marshfield Clinic 64 1.25
Journal of Competition Law and Economics journal 11978 Oxford University Press 34 0.94
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
World Englishes journal 7267 Wiley-Blackwell 68 2.38
Howard Journal of Communications journal 14582 Taylor and Francis Ltd. 42 1.27
Proceedings of the Technical Association of the Graphic Arts, TAGA conference and proceedings 30903 Technical Association of the Graphic 8 0.00
Museum Management and Curatorship journal 10490 Routledge 43 2.06
European Journal of Wildlife Research journal 10254 Springer Verlag 62 1.99
American Journal of Immunology (discontinued) journal 19764 Science Publications 12 1.56
Brain Imaging and Behavior journal 4582 Springer New York 72 2.86

Check complete list




Year wise Impact Score (IS) of Infectious Disorders - Drug Targets

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 1.26
2023 1.47
2022 1.40
2021 1.28
2020 1.42
2019 1.05
2018 0.87
2017 0.95
2016 1.39
2015 1.20
2014 1.72



Top Journals/Conferences in Medicine (miscellaneous)

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Research | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Nature Medicine
Nature Research | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Annual Review of Pathology: Mechanisms of Disease
Annual Reviews Inc. | United States

Physiological Reviews
American Physiological Society | United States

See All

Top Journals/Conferences in Microbiology (medical)

Nature Microbiology
Nature Research | United Kingdom

Clinical Microbiology Reviews
American Society for Microbiology | United States

Lancet Microbe, The
Elsevier Ltd | United Kingdom

Microbiome
BioMed Central Ltd | United Kingdom

Gut Microbes
Landes Bioscience | United States

Trends in Microbiology
Elsevier Ltd | United Kingdom

Clinical Infectious Diseases
Oxford University Press | United Kingdom

Clinical Microbiology and Infection
Elsevier B.V. | United Kingdom

Current Opinion in Microbiology
Elsevier Ltd | United Kingdom

Eurosurveillance
European Centre for Disease Prevention and Control (ECDC) | Sweden

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Research | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Genome Medicine
BioMed Central Ltd | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Experimental and Molecular Medicine
Springer Nature | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd | United Kingdom

EMBO Molecular Medicine
Springer Science and Business Media Deutschland GmbH | United Kingdom

See All